SCHEMBL20133258

SCHEMBL20133258

c1ccc(CO[C@H]2C[C@H](OCCCOCCOC3CCNCC3)C2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.49
SLC6A4 P31645 4/20 0.49
SLC6A3 Q01959 4/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
HTR7 P34969 1/20 0.49
HTR2B P41595 1/20 0.49
HTR3A P46098 1/20 0.49
HTR4 Q13639 1/20 0.49
HRH1 P35367 3/20 0.42
KCNH2 Q12809 2/20 0.41
REN P00797 3/20 0.41
HTR1A P08908 1/20 0.40
OPRM1 P35372 2/20 0.39
OPRL1 P41146 2/20 0.39
DPP4 P27487 1/20 0.39
GBA1 P04062 1/20 0.39
TMEM97 Q5BJF2 1/20 0.38
CARM1 Q86X55 1/20 0.38
PRMT6 Q96LA8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22906857 0.86 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL23267243 0.86 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL25308033 0.84 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL902002 0.83 SLC6A2 (0.66) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
Hydrochloric Acid SCHEMBL1532893 0.81 SLC6A2 (0.64) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL29079652 0.80 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL21673506 0.80 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL16339452 0.78 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL16339451 0.78 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL27691003 0.77 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912699-B2 Tau-protein targeting compounds and associated ARVINAS OPERATIONS, INC. (US) 2024-02-27 US disclosed
WO-2018102067-A2 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE Arvinas, Inc. (US) 2018-06-07 WO disclosed
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912699-B2 Tau-protein targeting compounds and associated MAPT, VHL, CRBN SLC6A2 3641/4885SLC6A4 3755/4885SLC6A3 3270/4885
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE CRBN, VHL, UBQLN2 SLC6A2 4090/4885SLC6A4 4312/4885SLC6A3 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.